FDA Enforcement Class II Ongoing

HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323

Recall: Z-2041-2025 · Reported July 9, 2025

Enforcement

Recall Number
Z-2041-2025
Event ID
96843
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Hardy Diagnostics
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
July 9, 2025
Initiation Date
May 6, 2025
Classification Date
June 27, 2025
Address
1430 W McCoy Ln, Santa Maria, CA, 93455-1005, United States

Description

HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323

Reason

Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.

Code Info

UDI-DI 008165760257704 G323 lot 653594P: Manufactured on March 6, 2025; Expires on May 15, 2025 G323 lot 655101P: Manufactured on April 4, 2025; Expires on June 13, 2025 G323 lot 656816P: Manufactured on April 16, 2025; Expires on June 25, 2025

Distribution

US domestic distribution to the following states: AZ, CA, CO, FL, GA, IL, MD, ME, MI, MN, MO, NC, NE, NV, NY, PA, PR, TX, UT, VA, WI and WV.

Quantity

4300 ea